Can I read HUB Organoids in Colorectal Cancer Drug Development on EtoBox?
HUB Organoids in Colorectal Cancer Drug Development by dnyanada is a document available to read on EtoBox.
What is HUB Organoids in Colorectal Cancer Drug Development about?
This case study demonstrates the use of HUB Organoids® to accelerate preclinical drug development, potentially reducing the timeline to clinical trials to five years. Traditional drug development methods often fail due to reliance on less relevant models, while patient-derived organoids provide a more accurate representation of tumor biology. The study highlights the successful identification and optimization of bispecific antibodies targeting colorectal cancer, showcasing the effectiveness of organoids in
- Author
- dnyanada
- Language
- EN